Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| Yesterday 4:30 PM View:  | Lowenthal Richard E President and CEO Director 10% Owner | Ars Pharmaceuticals, Inc. (SPRY) | 19-Nov-24 | Private Sale (Planned) Duplicate | 100,000 | $13.95 | $1,394,960.00 | (< 1%) 11.67M to 11.57M | |
| Yesterday 4:30 PM View: | Tanimoto Sarina Chief Medical Officer 10% Owner | Ars Pharmaceuticals, Inc. (SPRY) | 19-Nov-24 | Private Sale (Planned) | 100,000 | $13.95 | $1,394,960.00 | (< 1%) 11.67M to 11.57M | |
| 14-Nov-24 4:30 PM View: | Tanimoto Sarina Chief Medical Officer 10% Owner | Ars Pharmaceuticals, Inc. (SPRY) | 12-Nov-24 | Private Sale (Planned) Duplicate | 100,000 | $16.85 | $1,684,640.00 | (< 1%) 13.07M to 12.97M | |
| 14-Nov-24 4:30 PM View: | Lowenthal Richard E President and CEO Director 10% Owner | Ars Pharmaceuticals, Inc. (SPRY) | 12-Nov-24 | Private Sale (Planned) | 100,000 | $16.85 | $1,684,640.00 | (< 1%) 11.77M to 11.67M | |
| 10-Oct-24 4:28 PM View: | Tanimoto Sarina Chief Medical Officer 10% Owner | Ars Pharmaceuticals, Inc. (SPRY) | 08-Oct-24 | Private Sale (Planned) Duplicate | 100,000 | $13.83 | $1,382,770.00 | (< 1%) 11.97M to 11.87M | |
| 10-Oct-24 4:27 PM View: | Lowenthal Richard E President and CEO Director 10% Owner | Ars Pharmaceuticals, Inc. (SPRY) | 08-Oct-24 | Private Sale (Planned) | 100,000 | $13.83 | $1,382,770.00 | (< 1%) 11.97M to 11.87M | |
| 19-Sep-24 4:30 PM View: | Karas Eric Chief Commercial Officer | Ars Pharmaceuticals, Inc. (SPRY) | 18-Sep-24 | Planned Option Sale | 10,000 | $14.00 | $140,000.00 | (64%) 15.69K to 5.69K | |
| 19-Sep-24 4:30 PM View: | Karas Eric Chief Commercial Officer | Ars Pharmaceuticals, Inc. (SPRY) | 18-Sep-24 | Option Exercise | 10,000 | $1.50 | $15,000.00 | 176% 5.69K to 15.69K | |
| 19-Sep-24 4:29 PM View: | Tanimoto Sarina Chief Medical Officer 10% Owner | Ars Pharmaceuticals, Inc. (SPRY) | 17-Sep-24 | Private Sale (Planned) Duplicate | 100,000 | $12.93 | $1,293,210.00 | (< 1%) 12.07M to 11.97M | |
| 19-Sep-24 4:26 PM View: | Lowenthal Richard E President and CEO Director 10% Owner | Ars Pharmaceuticals, Inc. (SPRY) | 17-Sep-24 | Private Sale (Planned) | 100,000 | $12.93 | $1,293,210.00 | (< 1%) 12.07M to 11.97M | |
| 12-Sep-24 4:25 PM View: | Tanimoto Sarina Chief Medical Officer 10% Owner | Ars Pharmaceuticals, Inc. (SPRY) | 10-Sep-24 | Private Sale (Planned) | 100,000 | $11.50 | $1,149,780.00 | (< 1%) 12.17M to 12.07M | |
| 12-Sep-24 4:24 PM View: | Lowenthal Richard E President and CEO Director 10% Owner | Ars Pharmaceuticals, Inc. (SPRY) | 10-Sep-24 | Private Sale (Planned) Duplicate | 100,000 | $11.50 | $1,149,780.00 | (< 1%) 12.17M to 12.07M | |
| 28-Aug-24 4:26 PM View: | Orbimed Advisors LLC Director | Ars Pharmaceuticals, Inc. (SPRY) | 26-Aug-24 | Private Sale Duplicate | 83,695 | $13.00 | $1,088,040.00 | (< 1%) 8.37M to 8.29M | |
| 28-Aug-24 4:30 PM View: | Thompson Peter A Director | Ars Pharmaceuticals, Inc. (SPRY) | 26-Aug-24 | Private Sale | 83,695 | $13.00 | $1,088,040.00 | (< 1%) 8.37M to 8.29M | |
| 23-Aug-24 6:41 PM View: | Thompson Peter A Director | Ars Pharmaceuticals, Inc. (SPRY) | 23-Aug-24 | Sale Duplicate | 69,500 | $13.03 | $905,585.00 | (< 1%) 8.44M to 8.37M | |
| 23-Aug-24 6:38 PM View: | Orbimed Advisors LLC Director | Ars Pharmaceuticals, Inc. (SPRY) | 23-Aug-24 | Sale | 69,500 | $13.03 | $905,585.00 | (< 1%) 8.44M to 8.37M | |
| 23-Aug-24 6:38 PM View: | Orbimed Advisors LLC Director | Ars Pharmaceuticals, Inc. (SPRY) | 22-Aug-24 | Sale | 391,482 | $12.94 | $5,065,780.00 | (4%) 8.83M to 8.44M | |
| 23-Aug-24 6:41 PM View: | Thompson Peter A Director | Ars Pharmaceuticals, Inc. (SPRY) | 22-Aug-24 | Sale Duplicate | 391,482 | $12.94 | $5,065,780.00 | (4%) 8.83M to 8.44M | |
| 23-Aug-24 6:38 PM View: | Orbimed Advisors LLC Director | Ars Pharmaceuticals, Inc. (SPRY) | 21-Aug-24 | Private Sale | 407,700 | $13.56 | $5,526,600.00 | (4%) 9.24M to 8.83M | |
| 23-Aug-24 6:41 PM View: | Thompson Peter A Director | Ars Pharmaceuticals, Inc. (SPRY) | 21-Aug-24 | Private Sale Duplicate | 407,700 | $13.56 | $5,526,600.00 | (4%) 9.24M to 8.83M | |
| 21-Aug-24 6:49 PM View: | Scott Kathleen D. Chief Financial Officer | Ars Pharmaceuticals, Inc. (SPRY) | 20-Aug-24 | Option Exercise | 12,500 | $1.50 | $18,750.00 | 95% 13.2K to 25.7K | |
| 21-Aug-24 6:47 PM View: | Lowenthal Richard E President and CEO Director 10% Owner | Ars Pharmaceuticals, Inc. (SPRY) | 20-Aug-24 | Private Sale (Planned) | 100,000 | $15.03 | $1,502,590.00 | (< 1%) 12.27M to 12.17M | |
| 21-Aug-24 6:51 PM View: | Dorsey Brian Chief Operating Officer | Ars Pharmaceuticals, Inc. (SPRY) | 20-Aug-24 | Option Exercise | 50,000 | $0.64 | $32,000.00 | 830% 6.02K to 56.02K | |
| 21-Aug-24 6:49 PM View: | Scott Kathleen D. Chief Financial Officer | Ars Pharmaceuticals, Inc. (SPRY) | 20-Aug-24 | Planned Option Sale | 12,500 | $16.00 | $200,000.00 | (49%) 25.7K to 13.2K | |
| 21-Aug-24 6:51 PM View: | Dorsey Brian Chief Operating Officer | Ars Pharmaceuticals, Inc. (SPRY) | 20-Aug-24 | Planned Option Sale | 50,000 | $15.00 | $750,000.00 | (89%) 56.02K to 6.02K | |
| 21-Aug-24 6:48 PM View: | Tanimoto Sarina Chief Medical Officer 10% Owner | Ars Pharmaceuticals, Inc. (SPRY) | 20-Aug-24 | Private Sale (Planned) Duplicate | 100,000 | $15.03 | $1,502,590.00 | (< 1%) 12.27M to 12.17M | |
| 21-Aug-24 6:51 PM View: | Karas Eric Chief Commercial Officer | Ars Pharmaceuticals, Inc. (SPRY) | 19-Aug-24 | Option Exercise | 10,000 | $1.50 | $15,000.00 | 176% 5.69K to 15.69K | |
| 21-Aug-24 6:51 PM View: | Karas Eric Chief Commercial Officer | Ars Pharmaceuticals, Inc. (SPRY) | 19-Aug-24 | Planned Option Sale | 10,000 | $14.00 | $140,000.00 | (64%) 15.69K to 5.69K | |
| 15-Aug-24 4:30 PM View: | Dorsey Brian Chief Operating Officer | Ars Pharmaceuticals, Inc. (SPRY) | 13-Aug-24 | Planned Option Sale | 30,000 | $13.00 | $390,000.00 | (83%) 36.02K to 6.02K | |
| 15-Aug-24 4:30 PM View: | Tanimoto Sarina Chief Medical Officer 10% Owner | Ars Pharmaceuticals, Inc. (SPRY) | 13-Aug-24 | Private Sale (Planned) | 100,000 | $12.48 | $1,247,560.00 | (< 1%) 13.85M to 13.75M | |
| 15-Aug-24 4:30 PM View: | Dorsey Brian Chief Operating Officer | Ars Pharmaceuticals, Inc. (SPRY) | 13-Aug-24 | Option Exercise | 30,000 | $0.64 | $19,200.00 | 498% 6.02K to 36.02K | |
| 15-Aug-24 4:30 PM View: | Lowenthal Richard E President and CEO Director 10% Owner | Ars Pharmaceuticals, Inc. (SPRY) | 13-Aug-24 | Private Sale (Planned) Duplicate | 100,000 | $12.48 | $1,247,560.00 | (< 1%) 12.37M to 12.27M | |
| 18-Jul-24 4:30 PM View: | Tanimoto Sarina Chief Medical Officer 10% Owner | Ars Pharmaceuticals, Inc. (SPRY) | 16-Jul-24 | Private Sale (Planned) Duplicate | 100,000 | $11.40 | $1,140,300.00 | (< 1%) 12.47M to 12.37M | |
| 18-Jul-24 4:30 PM View: | Lowenthal Richard E President and CEO Director 10% Owner | Ars Pharmaceuticals, Inc. (SPRY) | 16-Jul-24 | Private Sale (Planned) | 100,000 | $11.40 | $1,140,300.00 | (< 1%) 12.47M to 12.37M | |
| 11-Jul-24 5:03 PM View: | Lowenthal Richard E President and CEO Director 10% Owner | Ars Pharmaceuticals, Inc. (SPRY) | 09-Jul-24 | Private Sale (Planned) Duplicate | 100,000 | $9.62 | $961,725.00 | (< 1%) 12.57M to 12.47M | |
| 11-Jul-24 5:04 PM View: | Tanimoto Sarina Chief Medical Officer 10% Owner | Ars Pharmaceuticals, Inc. (SPRY) | 09-Jul-24 | Private Sale (Planned) | 100,000 | $9.62 | $961,725.00 | (< 1%) 12.57M to 12.47M | |
| 17-Jun-24 6:39 PM View: | Shah Pratik Director | Ars Pharmaceuticals, Inc. (SPRY) | 13-Jun-24 | Gift | 1,332,900 | -- | -- | (22%) 6.16M to 4.82M | |
| 13-Jun-24 4:30 PM View: | Tanimoto Sarina Chief Medical Officer 10% Owner | Ars Pharmaceuticals, Inc. (SPRY) | 12-Jun-24 | Sale (Planned) | 95,862 | $9.15 | $876,663.00 | (< 1%) 12.66M to 12.57M | |
| 13-Jun-24 4:30 PM View: | Lowenthal Richard E President and CEO Director 10% Owner | Ars Pharmaceuticals, Inc. (SPRY) | 12-Jun-24 | Sale (Planned) Duplicate | 95,862 | $9.15 | $876,663.00 | (< 1%) 12.66M to 12.57M | |
| 13-Jun-24 4:30 PM View: | Tanimoto Sarina Chief Medical Officer 10% Owner | Ars Pharmaceuticals, Inc. (SPRY) | 11-Jun-24 | Private Sale (Planned) | 4,138 | $9.00 | $37,254.00 | (< 1%) 12.67M to 12.66M | |
| 13-Jun-24 4:30 PM View: | Lowenthal Richard E President and CEO Director 10% Owner | Ars Pharmaceuticals, Inc. (SPRY) | 11-Jun-24 | Private Sale (Planned) Duplicate | 4,138 | $9.00 | $37,254.00 | (< 1%) 12.67M to 12.66M | |
| 07-Jun-24 9:11 PM View: | Shah Pratik Director 10% Owner | Ars Pharmaceuticals, Inc. (SPRY) | 07-Jun-24 | Gift | 1,332,950 | -- | -- | (18%) 7.49M to 6.16M | |
| 06-Jun-24 4:32 PM View: | Shah Pratik Director 10% Owner | Ars Pharmaceuticals, Inc. (SPRY) | 04-Jun-24 | Gift | 1,332,900 | -- | -- | (12%) 11.49M to 10.16M | |
| 06-Jun-24 4:32 PM View: | Shah Pratik Director 10% Owner | Ars Pharmaceuticals, Inc. (SPRY) | 04-Jun-24 | Gift | 1,332,900 | -- | -- | 13% 10.16M to 11.49M | |
| 06-Jun-24 4:32 PM View: | Shah Pratik Director 10% Owner | Ars Pharmaceuticals, Inc. (SPRY) | 04-Jun-24 | Disposition (other) | 2,665,800 | -- | -- | (26%) 10.16M to 7.49M | |
| 16-May-24 7:51 PM View: | Lowenthal Richard E President and CEO Director 10% Owner | Ars Pharmaceuticals, Inc. (SPRY) | 16-May-24 | Sale (Planned) | 89,096 | $9.06 | $807,023.00 | (< 1%) 14.4M to 14.31M | |
| 16-May-24 7:52 PM View: | Tanimoto Sarina Chief Medical Officer 10% Owner | Ars Pharmaceuticals, Inc. (SPRY) | 16-May-24 | Sale (Planned) Duplicate | 89,096 | $9.06 | $807,023.00 | (< 1%) 12.75M to 12.67M | |
| 16-May-24 7:52 PM View: | Tanimoto Sarina Chief Medical Officer 10% Owner | Ars Pharmaceuticals, Inc. (SPRY) | 15-May-24 | Sale (Planned) Duplicate | 5,147 | $9.05 | $46,564.70 | (< 1%) 12.76M to 12.75M | |
| 16-May-24 7:51 PM View: | Lowenthal Richard E President and CEO Director 10% Owner | Ars Pharmaceuticals, Inc. (SPRY) | 15-May-24 | Sale (Planned) | 5,147 | $9.05 | $46,564.70 | (< 1%) 14.4M to 14.4M | |
| 16-May-24 7:52 PM View: | Tanimoto Sarina Chief Medical Officer 10% Owner | Ars Pharmaceuticals, Inc. (SPRY) | 14-May-24 | Private Sale (Planned) Duplicate | 5,757 | $9.01 | $51,853.90 | (< 1%) 12.77M to 12.76M |
